Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hans M.G. Princen"'
Autor:
E.H. Offerman, Astrid Trion, Arnoud van der Laarse, Wouter Jukema, Moniek P.M. de Maat, Louis M. Havekes, Jef J. Emeis, Annemarie C.E. Maas, Hans M.G. Princen, Alexander J. Szalai
Publikováno v:
Journal of Cardiovascular Pharmacology, 47(1), 89-95. Lippincott Williams & Wilkins
We investigated the pleiotropic effects of a calcium antagonist (amlodipine) on early atherosclerosis development in the presence and absence of an HMG-CoA-reductase inhibitor (atorvastatin) in apolipoprotein E*3-Leiden/human C-reactive protein (E3L/
Autor:
Gerwin J. Puppels, J. Wouter Jukema, Sweder W.E van de Poll, Louis M. Havekes, Hans M.G. Princen, Arnoud van der Laarse, Dianne J.M. Delsing
Publikováno v:
Journal of Molecular and Cellular Cardiology, 35(1), 109-118. Academic Press
Combined treatment of statins and calcium channel blockers has been suggested to be superior to statin therapy alone. We quantified the anti-atherosclerotic potential of amlodipine, atorvastatin and their combination on existing atherosclerotic plaqu
Autor:
Oscar L. Volger, Louis M. Havekes, Sweder W.E van de Poll, Hans M.G. Princen, Gerwin J. Puppels, Arnoud van der Laarse, Dianne J.M. Delsing, J. Wouter Jukema, Tjeerd J. Römer, Tom C. Bakker Schut
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 21:1630-1635
Quantitative characterization of atherosclerotic plaque composition with standard histopathological methods remains limited to sectioned plaques. Raman spectroscopy enables nondestructive quantification of atherosclerotic plaque composition. We used
Autor:
Gene Liau, Hans M.G. Princen, José W.A. van der Hoorn, Anita M. van den Hoek, J. Wouter Jukema, Louis M. Havekes, Susan Kühnast
Publikováno v:
Journal of Hypertension, 1, 30, 107-116
Journal of Hypertension, 30(1), 107-116
Journal of Hypertension, 30(1), 107-16
Journal of Hypertension, 30(1), 107-116
Journal of Hypertension, 30(1), 107-16
Objective: Aliskiren is the first commercially available, orally active, direct renin inhibitor approved to treat hypertension. The renin-angiotensin system has been shown to be a significant contributor to the development of hypercholesterolemia-ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcbe2be8b56e63327af1e3e80f95671b
https://hdl.handle.net/1887/111167
https://hdl.handle.net/1887/111167
Autor:
Hans M.G. Princen, E.H. Offerman, Teake Kooistra, Alexander J. Szalai, Robert Kleemann, Sjef J. Emeis, Lars Verschuren
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 25(1)
Objective - To evaluate whether low-dose atorvastatin suppresses atherosclerotic lesion progression and inflammation in apolipoprotein E*3 (apoE*3)-Leiden mice beyond its cholesterol-lowering effect. Methods and Results - ApoE*3-Leiden mice were fed
Autor:
Sweder W.E van de Poll, Gerwin J. Puppels, Hans M.G. Princen, Louis M. Havekes, Arnoud van der Laarse, Dianne J.M. Delsing, J. Wouter Jukema
Publikováno v:
Atherosclerosis. 164(1)
Raman spectroscopy allows quantitative, non-destructive evaluation of entire, intact atherosclerotic plaques. We quantified the anti-atherosclerotic effects of atorvastatin and amlodipine on progression of atherosclerosis using post-mortem Raman spec